Plans to Build a New State-of-theArt Manufacturing Facility - Lupin Ltd

Code BSE: 500257 NSE:

Lupin Announces Plans to Build a New State-of-theArt Manufacturing Facility in Coral Springs, Florida Extending its LongStanding Commitment to America’s Patients and Healthcare System   The expansion of Lupin’s footprint in Coral Springs is a core part of our growth strategy. This new state-of-the-art facility will build on our existing presence in Florida, which is home to Lupin’s headquarters and our Advanced Inhalation Research Center. This investment demonstrates Lupin’s commitment to innovation, quality and supply chain reliability — and our ability to partner with Florida’s leaders to strengthen America’s medicine security by growing our capacity to produce affordable treatments for patients. We are grateful to Florida’s leadership for their partnership in making this possible,” said Christoph Funke, Chief Technical Operations Officer, Lupin.